149 related articles for article (PubMed ID: 15779008)
1. TSH receptor protein is selectively expressed in normal human extraocular muscle.
Kloprogge SJ; Busuttil BE; Frauman AG
Muscle Nerve; 2005 Jul; 32(1):95-8. PubMed ID: 15779008
[TBL] [Abstract][Full Text] [Related]
2. The full length and splice variant thyrotropin receptor is expressed exclusively in skeletal muscle of extraocular origin: a link to the pathogenesis of Graves' ophthalmopathy.
Major BJ; Cures A; Frauman AG
Biochem Biophys Res Commun; 1997 Jan; 230(3):493-6. PubMed ID: 9015347
[TBL] [Abstract][Full Text] [Related]
3. Immunization of mice with a newly identified thyroid-stimulating hormone receptor splice variant induces Graves'-like disease.
Endo T; Kobayashi T
J Autoimmun; 2013 Jun; 43():18-25. PubMed ID: 23538203
[TBL] [Abstract][Full Text] [Related]
4. Detection of the novel autoantibody (anti-UACA antibody) in patients with Graves' disease.
Ohkura T; Taniguchi S; Yamada K; Nishio N; Okamura T; Yoshida A; Kamijou K; Fukata S; Kuma K; Inoue Y; Hisatome I; Senju S; Nishimura Y; Shigemasa C
Biochem Biophys Res Commun; 2004 Aug; 321(2):432-40. PubMed ID: 15358194
[TBL] [Abstract][Full Text] [Related]
5. Multiple forms of thyroid stimulating hormone receptor associated with Graves' disease.
Hunt N; Willey KP; Jähner D; Ivell R; Northemann W; Castel MA; Leidenberger F
Exp Clin Endocrinol; 1992; 100(1-2):22-7. PubMed ID: 1468510
[No Abstract] [Full Text] [Related]
6. Immunohistochemical staining of normal and Graves' extraocular muscle.
Tallstedt L; Norberg R
Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):175-84. PubMed ID: 2448263
[TBL] [Abstract][Full Text] [Related]
7. Extrathyroidal manifestations of Graves' disease: the thyrotropin receptor is expressed in extraocular, but not cardiac, muscle tissues.
Busuttil BE; Frauman AG
J Clin Endocrinol Metab; 2001 May; 86(5):2315-9. PubMed ID: 11344244
[TBL] [Abstract][Full Text] [Related]
8. In situ expression of thyrotropin receptor in the extraocular muscles of patients with thyroid-associated ophthalmopathy.
Chen J; Wei RL; He J; Ma XY
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):7-10. PubMed ID: 14724083
[TBL] [Abstract][Full Text] [Related]
9. Expression of IFNalpha-inducible genes and modulation of HLA-DR and thyroid stimulating hormone receptors in Graves' disease.
Kuang M; Wang S; Wu M; Ning G; Yao Z; Li L
Mol Cell Endocrinol; 2010 May; 319(1-2):23-9. PubMed ID: 20015465
[TBL] [Abstract][Full Text] [Related]
10. Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy.
Boschi A; Daumerie Ch; Spiritus M; Beguin C; Senou M; Yuksel D; Duplicy M; Costagliola S; Ludgate M; Many MC
Br J Ophthalmol; 2005 Jun; 89(6):724-9. PubMed ID: 15923509
[TBL] [Abstract][Full Text] [Related]
11. Serum antibodies reactive with eye muscle antigens and the TSH receptor in a euthyroid subject who developed ophthalmopathy and Graves' hyperthyroidism.
Wall J; Barsouk A; Stolarski C; Kiljanski J; Stachura I; Nebes V; Peele K; Volpe R; Kennerdell J
Thyroid; 1996 Aug; 6(4):353-8. PubMed ID: 8875760
[TBL] [Abstract][Full Text] [Related]
12. Extraocular muscle autoimmunity and orbital fat inflammation in thyroid-associated ophthalmopathy.
Tani J; Gopinath B; Nguyen B; Wall JR
Expert Rev Clin Immunol; 2007 May; 3(3):299-311. PubMed ID: 20477674
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of thyrotropin receptor mRNA in orbital fat and eye muscle tissues from patients with Graves' ophthalmopathy by in situ hybridization.
Wu SL; Yang CS; Wang HJ; Liao CL; Chang TJ; Chang TC
J Endocrinol Invest; 1999 Apr; 22(4):289-95. PubMed ID: 10342363
[TBL] [Abstract][Full Text] [Related]
14. [Current understanding of pathogenesis of Graves ophthalmopathy].
Ando T; Eguchi K
Nihon Rinsho; 2006 Dec; 64(12):2275-8. PubMed ID: 17154091
[TBL] [Abstract][Full Text] [Related]
15. Graves' ophthalmopathy evolution studied by MRI during childhood and adolescence.
Antoniazzi F; Zamboni G; Cerini R; Lauriola S; Dall'Agnola A; Tatò L
J Pediatr; 2004 Apr; 144(4):527-31. PubMed ID: 15069405
[TBL] [Abstract][Full Text] [Related]
16. [Immunopathology of Graves'-Basedow disease].
Baj Z; Ferenc T; Lewiński A
Postepy Hig Med Dosw; 1997; 51(5):531-46. PubMed ID: 9489453
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune thyroid diseases: genetic susceptibility of thyroid-specific genes and thyroid autoantigens contributions.
Hadj-Kacem H; Rebuffat S; Mnif-Féki M; Belguith-Maalej S; Ayadi H; Péraldi-Roux S
Int J Immunogenet; 2009 Apr; 36(2):85-96. PubMed ID: 19284442
[TBL] [Abstract][Full Text] [Related]
18. Analysis of human thyrotropin receptor gene expression and immunoreactivity in human orbital tissue.
Spitzweg C; Joba W; Hunt N; Heufelder AE
Eur J Endocrinol; 1997 Jun; 136(6):599-607. PubMed ID: 9225723
[TBL] [Abstract][Full Text] [Related]
19. Expression of thioredoxin in patients with Graves' disease.
Kihara M; Kontani K; Yamauchi A; Miyauchi A; Nakamura H; Yodoi J; Yokomise H
Int J Mol Med; 2005 May; 15(5):795-9. PubMed ID: 15806300
[TBL] [Abstract][Full Text] [Related]
20. Cardiomyopathy associated with Graves' disease.
Koshiyama H; Sellitti DF; Akamizu T; Doi SQ; Takeuchi Y; Inoue D; Sakaguchi H; Takemura G; Sato Y; Takatsu Y; Nakao K
Clin Endocrinol (Oxf); 1996 Jul; 45(1):111-6. PubMed ID: 8796147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
